Notices

The listing of bevacizumab is based on a formal requirement by the US Food and Drug Administration that the chemical be identified or labeled as causing reproductive toxicity.

This request is limited to exposures to crystalline silica (airborne particles of respirable size) from the four specified WOODWISE® wood filler products.

The regulation will be effective on April 1, 2019.  This regulation establishes a No Significant Risk Level of 0.95 micrograms per day for bromodichloroacetic acid for purposes of Proposition 65.

The regulation will be effective on April 1, 2019.  This regulation establishes a No Significant Risk Level of 0.70 micrograms per day for bromochloroacetic acid for purposes of Proposition 65.

The following is a list of cases related to the Safe Drinking Water and Toxic Enforcement Act 1986 (commonly known as Proposition 65).  It is provided for informational purposes only and shoul

The committee considered N-Nitrosohexamethyleneimine and gentian violet for listing as known to the state to cause cancer.

The committee considered nickel and nickel compounds for listing as known to the state to cause reproductive toxicity. A summary of the meeting, meeting agenda, and transcript are available.

The committee considered nickel and nickel compounds for listing as known to the state to cause reproductive toxicity. A summary of the meeting, meeting agenda, and transcript are available.

This action amends Section 25603 to allow alternative signal words for on-product Proposition 65 warnings for pesticides regulated under the Federal Insecticide, Fungicide and Rodenticide Act.

OEHHA has scheduled a public hearing on Thursday, January 3, 2019, at the George Alexeeff Environmental Health Library, Suite 1604, 16th Floor, 1515 Clay Street, Oakland, CA 94612 and the comment period is extended to 5:00 pm, Friday, January 11, 2019.

At a public meeting on November 1, 2018, the Carcinogen Identification Committee (CIC) in its official capacity as the “state’s qualified experts” (SQE) determined that gentian violet and N-nitrosohexamethyleneimine were clearly shown by scientifically valid testing according to generally accepted principles to cause cancer.

The basis for the modification of the listing was described in a public notice published in the August 3, 2018 issue of the California Regulatory Notice Register (Register 2018, No. 31-Z).

OEHHA is requesting comments as to whether p‑chloro‑α,α,α-trifluorotoluene meets the criteria set forth in the Proposition 65 regulations for authoritative bodies listings.  In order to be considered, OEHHA must receive comments by 5:00 p.m. on December 24, 2018.

In August 2016, OEHHA adopted the new Article 6 of Title 27, California Code of Regulations, Section 25600 et seq. OEHHA adopted amendments to the regulations on November 20, 2017 to clarify and make more specific certain provisions of Article 6.  Based upon questions received and additional input from stakeholders, this rulemaking proposes additional clarifying changes to Section 25600.2, subsections (b), (c), and (f).

The comment period will now close on 5:00 pm, Monday, December 3, 2018.

Effective October 26, 2018, the Office of Environmental Health Hazard Assessment (OEHHA) is adding Nickel (soluble compounds) to the list of chemicals known to the state to cause reproduct

The Office of Environmental Health Hazard Assessment announces the availability of a tentative agenda for the Carcinogen Identification Committee meeting to be held on November 1.

OEHHA is requesting comments on the modifications to the regulatory text.  In order to be considered, OEHHA must receive comments by 5:00 p.m. on November 7, 2018, the designated close of the comment period.  All comments will be posted on the OEHHA website at the close of the public comment period.

OEHHA is extending the public comment period on this proposed amendment to 5:00 pm, Monday, November 26, 2018 and has scheduled a public hearing on Monday, November 19, 2018.

The California Environmental Protection Agency’s Office of Environmental Health Hazard Assessment (OEHHA) intends to list bevacizumab as known to the state to cause reproductive toxicity (developmental and female endpoints) under the Safe Drinking Water and Toxic Enforcement Act of 198.